The effectiveness of a training for patients with unexplained physical symptoms: protocol of a cognitive behavioral group training and randomized controlled trial by Zonneveld, Lyonne NL et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Public Health
Open Access Study protocol
The effectiveness of a training for patients with unexplained physical 
symptoms: protocol of a cognitive behavioral group training and 
randomized controlled trial
Lyonne NL Zonneveld*1,2, Adriaan van 't Spijker2, Jan Passchier2, Jan J van 
Busschbach2 and Hugo J Duivenvoorden2
Address: 1Riagg Rijnmond, Westhavenkade 85, 3133 AV Vlaardingen, the Netherlands and 2Erasmus Medical Center, Department of Medical 
Psychology and Psychotherapy, PO Box 2040, 3000 CA Rotterdam, the Netherlands
Email: Lyonne NL Zonneveld* - l.zonneveld@erasmusmc.nl; Adriaan van 't Spijker - a.vantspijker@erasmusmc.nl; 
Jan Passchier - j.passchier@erasmusmc.nl; Jan J van Busschbach - j.vanbusschbach@erasmusmc.nl; 
Hugo J Duivenvoorden - h.duivenvoorden@erasmusmc.nl
* Corresponding author    
Abstract
Background: In primary care, up to 74% of physical symptoms is classified as unexplained. These
symptoms can cause high levels of distress and healthcare utilization. Cognitive behavioral therapy
has shown to be effective, but does not seem to be attractive to patients. An exception herein is a
therapy based on the consequences model, which distinguishes itself by its labeling of psychosocial
distress in terms of consequences rather than as causes of physical symptoms. In secondary care,
81% of the patients accepts this therapy, but in primary care the outcome is poor. We assume that
positive outcome can also be reached in primary care, when the consequences model is modified
and used bottom-up in an easily accessible group training, in which patients are relieved of being
blamed for their symptoms. Our aim is to investigate the (cost-)effectiveness of this training.
Methods and design: A randomized controlled trial is designed. One hundred patients are
randomized to either the group training or the waiting list.
Physicians in general practices and outpatients clinics of general hospitals refer patients. Referral
leads to inclusion if patients are between 18 and 65 years old, understand Dutch, have no handicaps
impeding participation and the principal DSM-IV-TR classification is undifferentiated somatoform
disorder or chronic pain disorder. In contrast to other treatment effect studies, the co-morbidity
of a personality disorder does not lead to exclusion. By this, we optimize the comparability
between the study population and patients in daily practice enlarging the generalization possibilities.
Also in contrast to other effect studies, we chose quality of life (SF-36) instead of physical
symptoms as the primary outcome measure. The SF-6D is used to estimate Quality Adjusted Life
Years (QALYs). Costs are measured with the Trimbos/iMTA Questionnaire for Costs associated
with Psychiatric Illness. Measurements are scheduled at baseline, after the training or waiting list,
three and twelve months after the training. The differences between measurements are analyzed
according to the intention-to-treat principle. The cost-effectiveness is expressed as costs per
QALY, using multiple sensitivity analyses on the basis of a probabilistic model of the trial.
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Discussion: If we show that our group training is (cost-)effective, more patients could be served,
their quality of life could be improved while costs might be reduced. As the training is investigated
in a heterogeneous patient group in the daily practice of a mental healthcare institution, its transfer
to practice should be relatively easy.
Trial registration: Nederlands Trial Register, NTR1609
Background
The estimated prevalence of unexplained physical symp-
toms in primary care ranges from 18 to 74% [1,2]. This
huge difference in estimating prevalence is caused by mul-
tiple definitions of unexplained physical symptoms such
as Unexplained Physical Symptoms (UPS), Medical Unex-
plained Physical Symptoms (MUPS), functional somatic
syndromes and abridged somatization. We use the Diag-
nostic and Statistical Manual of Mental Disorders IV -Text
Revision (DSM-IV-TR) [3] and define unexplained physi-
cal symptoms with the classification of 'undifferentiated
somatoform disorder' and 'chronic pain disorder'. In the
Netherlands, the estimated prevalence of unexplained
physical symptoms in primary care is 18% [2]. Most of
these unexplained physical symptoms can be classified as
a somatoform disorder, of which 13.0% meets the criteria
of undifferentiated somatoform disorder and 1.6% meets
the criteria of chronic pain disorder [4]. In general, the
DSM-IV-TR classifies symptoms without making assump-
tions about etiology. However, the DSM-IV-TR does pre-
sume psychological causes in the beginning, severity,
increase or continuation of pain in chronic pain disorder.
Therefore, we prefer to use the mere descriptive term
'Unexplained Physical Symptoms (UPS)', which corre-
sponds with the DSM-IV-TR terms 'undifferentiated
somatoform disorder' and 'chronic pain disorder' with the
exception of the assumptions about etiology.
Patients with UPS have high levels of psychosocial distress
and healthcare utilization [5], for which cognitive behav-
ioral therapy is shown to be most effective [6-9]. However,
it is widely believed, that patients with unexplained phys-
ical symptoms reject this kind of therapy. The conse-
quences model is a positive exception. The key difference
of this model compared to other cognitive behavioral
models is its labeling of psychosocial distress in terms of
consequences rather than as causes of UPS. Herewith, the
consequences model fits both professionals' and patients'
point of view. Refraining from labeling psychosocial dis-
tress as causes of UPS corresponds with the lack of consen-
sus among professionals about the causes of UPS, which
is reflected in the ongoing debate about the position of
somatoform disorders on Axis I or III in the next edition
of Diagnostic and Statistical Manual of Mental Disorders
[10,11]. Moreover, labeling psychosocial distress as con-
sequences, matches the patients' perspective of UPS. This
is reflected in the fact, that 81% of the patients in aca-
demic medical care accepts an individual therapy based
on the consequences model [12] and this individual ther-
apy has positive outcomes in secondary care [13]. Unfor-
tunately, in primary care, this high acceptance rate could
not be reproduced and resulted in poor outcome [2,14].
We assume that the consequences model can maintain its
positive outcome for patients in primary care, when we
make some modifications. Firstly, we tailor this model
more accurately to patients' perspective of their physical
symptoms. Moreover, we put additional attention to
relieve patients from being blamed for their symptoms.
Furthermore, we make the group training easy accessible.
Our aim is to investigate the (cost-)effectiveness of this
easily accessible group training for patients in primary
care conducted in the daily practice of our mental health-
care institution, Riagg Rijnmond, The Netherlands. This
study protocol provides a detailed description of the cog-
nitive behavioral group training and the design of the ran-
domized controlled trial investigating the (cost-
)effectiveness of this training.
Objectives
The primary aim of this study is to investigate (cost-)effec-
tiveness of our easily accessible protocollized group train-
ing for patients with UPS in primary care conducted in the
daily practice of a mental healthcare institution. The sec-
ondary aim is to identify (personality-)variables enabling
to predict this (cost-)effectiveness.
Methods and design
Design
The (cost-)effectiveness of the group training is evaluated
in a randomized controlled trial (see Figure 1).
The study started February 2005. The inclusion of patients
has ended in September 2008. The one-year follow-up
period of the randomized patients will be finished in April
2010.
Study population
Patients are included when:
1. they are between 18 and 65 years old;
2. they are able to speak, read and write Dutch;BMC Public Health 2009, 9:251 http://www.biomedcentral.com/1471-2458/9/251
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Design of the randomized controlled trial Figure 1
Design of the randomized controlled trial.
Referral of patients, inclusion criteria: 
• Between 18 and 65 years 
• Being able to speak, read and write Dutch 
• UPS at least 6 months 
Dropout: 
• Losses 
  Informed consent of patients: 
• Interview to inform patient about study 
• Signed informed consent 
Dropout: 
• Losses 
• No informed consent  Assessment of eligibility: 
• SCID I: -undifferentiated somatoform disorder or 
 -pain  disorder 
Assessment of personality: 
• VKP 
Dropout: 
• Losses 
• Ineligibility  Baseline  
outcome measurement
Dropout: 
• Losses 
  Randomization 
Group training  Waiting list 
Dropout: 
• Losses
Dropout: 
• Losses
Follow-up measurement I 
3 months after training 
Follow-up measurement II 
12 months after training 
Outcome measurement  Outcome measurement 
Dropout: 
• Losses
Group training 
Dropout: 
• Losses
Follow-up measurement I 
3 months after training 
Follow-up measurement II 
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3. their UPS persists at least 6 months;
4. their UPS is classified as undifferentiated somatoform
disorder or chronic pain disorder according to the criteria
of the Structured Clinical Interview for DSM-IV Axis I Dis-
orders/Patient edition (SCID-I/P) [15].
Patients are excluded when:
1. UPS is not the principal somatic disease;
2. undifferentiated somatoform disorder or chronic pain
disorder is not the principal DSM-IV-TR classification;
3. handicaps like cognitive mental impairment and/or
blindness impending the patient to participate in the
training.
To optimize the comparability between the study popula-
tion and the patients with UPS in daily practice and to
make generalization to daily practice possible, we have
decided that having a personality disorder is not an exclu-
sion criterion; this is in contrast to other treatment effect
studies. We do measure personality disorder with the self-
report questionnaire for DSM-IV Axis II personality disor-
ders (VKP) based on the International Personality Disor-
der Examination (IPDE) [16]. By measuring personality
disorders using this instrument, we can not only describe
the study population in terms of personality disorders,
but also identify the influence of personality disorders on
(cost-)effectiveness.
Patients are recruited from general practices and outpa-
tient clinics of general hospitals in and nearby Rotterdam,
the Netherlands. Physicians' attention is drawn to the
group training by periodical postcards informing them
when and how they can refer patients to the group train-
ing. Patients' attention is drawn to the group training by
announcements in local newspapers and on websites of
patients' associations, in which they are asked to make an
appointment with their physician to discuss referral when
interested. Physicians decide whether the physical symp-
toms are medically explained or unexplained hereby
checking the first exclusion criterion, after which they
refer patients when they find this appropriate. After refer-
ral, patients are invited for an interview, preferably in a
medical setting, in which they are verbally and in writing
informed about the study. In this interview, the first three
inclusion criteria and the last exclusion criterion are veri-
fied. After receiving patients' signed informed consent,
patients are invited for a second interview, in which the
last inclusion criterion and the second exclusion criterion
are investigated by the Structured Clinical Interview for
DSM-IV Axis I Disorders/Patient edition (SCID-I/P)
administered by independent psychologists. These psy-
chologists make the final decision based on the results of
the SCID-I/P whether patients' UPS can be classified as an
undifferentiated somatoform disorder or as a chronic pain
disorder and whether this disorder is the principal DSM-
IV-TR classification. If undifferentiated somatoform disor-
der or chronic pain disorder is the principal DSM-IV-TR
classification, then patients complete the self-report ques-
tionnaire for DSM-IV Axis II personality disorders (VKP).
Right before the start of each next training, the newly
included patients fill in the questionnaires. Subsequently,
an independent statistician randomizes them to either the
group training or waiting list with a computer-based 1:1
ratio randomization procedure. The results of this rand-
omization procedure are sent to the patient by letter. If
randomization leads to starting with the group training,
then an invitation for the group training is enclosed in the
randomization letter. After the group training or after a
waiting-period of the same length as the group training,
all patients fill in the questionnaires for the second time.
After filling in the outcome measurements for the second
time, the patients on the waiting list are invited to the
group training. They follow the group training after their
waiting period together with the newly included patients
randomized to the group training in the most recent ran-
domization. For patients on the waiting list, a longer wait-
ing period is not feasible, because the study is conducted
in the daily practice of a real life mental healthcare insti-
tution. By combining the patients assigned by the previ-
ous randomization to the waiting list with the patients
assigned by the next randomization to the group training
in the same training, the patients in both conditions
receive exactly the same training. After completing the
training, all patients fill in follow-up measurements after
three months and after one year.
Experimental condition: group training
The group training [17] is based on the consequences
model, which labels psychosocial stress as consequences
rather than as causes of UPS to prevent the suggestion that
'its all in the head'. The original consequences model [18]
assumes that UPS induces irrational beliefs regarding the
symptoms resulting in consequences, which maintain or
increase UPS (see black arrows in Figure 2). Its implemen-
tation in an individual therapy starts with beliefs labeling
them as irrational, disputing them and replacing them
with rational ones. Subsequently, other consequences are
changed to break the vicious circle [19]. The ultimate goal
is to reduce physical symptoms.
We assume that this original consequences model has not
completely succeeded in preventing the 'its all in the head'
suggestion. After all, patients might perceive the focus on
irrational beliefs still as 'its all in the head'. Patients mightBMC Public Health 2009, 9:251 http://www.biomedcentral.com/1471-2458/9/251
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experience the disputing of these beliefs as blaming and
belittling. Blaming and belittling result in a rejection of
the therapy by patients and in poor outcome [20,21]. That
is why we modify the consequences model for our group
training (see red arrows in Figure 2). Our group training
focuses on the visible consequences, labeling them as sur-
vival strategies in reaction to physical symptoms, justify-
ing their existence by their benefit in short term, albeit
indicating their harmfulness in the long run and therefore
replacing them with long run beneficial strategies. Subse-
quently, the underlying beliefs of these survival strategies
are explored, checked and, if necessary, changed in more
helpful ones. Finally, the problem-solving model of Nezu
et al. [22] is introduced to facilitate developing personal
effective survival strategies for all kinds of problems,
acknowledging that physical symptoms can increase the
number of problems. The ultimate goal is not aimed at
reducing physical symptoms as with the original conse-
quences model, but is aimed at improving quality of life.
In summary, the group training uses the consequences
model bottom-up instead of the commonly used top-
down approach. By using the consequences model bot-
tom-up (starting with consequences and unconditionally
accepting and justifying their existence) instead of top-
down (starting with addressing irrational beliefs and dis-
puting them), we reach a closer match with the patients'
physical point of view. Moreover, patients are relieved
from being blamed, called exoneration, by justifying the
existence of consequences by their benefit in short term,
by which we facilitate compliance. Furthermore, we tailor
the setting of the training to patients' physical point of
view by organizing the training in a medical healthcare
setting and not in our own mental healthcare institution.
Herewith, also the implicit but unintended 'its all in the
head' suggestion is avoided.
This bottom-up strategy results in a group training com-
prising thirteen ad verbatim protocollized weekly sessions
of two hours each.
After session 1, the structure of each session is as follows:
• sharing experiences of the past week;
￿ discussing home-assignments;
￿ doing a group breathing and relaxation exercise;
Modified consequences model based on Speckens et al. [18,19] Figure 2
Modified consequences model based on Speckens et al. [18,19].
 
Physical symptoms 
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(processed and integrated information) 
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social 
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over-breathing  over-activity  sadness 
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￿ identifying short-term beneficial survival strategies and
modifying them into long-term beneficial ones;
￿ ending with a summary of the session and new home-
assignments.
Each session is built around a theme. In session 1, trainees
get acquainted with each other by telling each other about
their symptoms and by setting their personal goals for the
training.
In session 2, the flight-fight cycle and habits in reaction to
symptoms are identified as survival strategies of the body
and modified with the learning of the breathing and relax-
ation exercise and the reshaping of habits into long-term
beneficial ones.
In session 3, avoidance and overactivity in reaction to
symptoms are identified as survival strategies of the body
and modified by scheduling different kinds of activities in
a feasible pace alternated with short breaks (5 to 10 min-
utes) that is compatible with the trainees' physical condi-
tion.
In session 4, emotions in reaction to symptoms are iden-
tified as useful survival strategies indicating the need for
problem-solving. Moreover, the physical symptoms of
emotions are notified and reduced or even relieved with
the breathing and relaxation exercise.
In session 5, thoughts in reaction to symptoms are identi-
fied as survival strategies of the mind and, if necessary,
modified with the Ellis' ABCDE scheme into more helpful
ones.
In session 6, a good physical shape is identified as an
effective survival strategy of the body, which can be
achieved by doing a low cardiac physical activity (like
walking or biking) twice a day and increasing this up to a
maximum of 60 minutes twice a day, after which physical
shape can be maintained by a regular sport twice a week.
In session 7, the form at Figure 2 is filled in by the trainees
and discussed afterwards with an important and trusted
person in his or her own social environment.
In sessions 8 to 12, the five steps of the problem-solving
method (problem-attitude, problem-definition, alterna-
tive solutions, solution plan, solution implementation
and evaluation) are identified and practiced.
In session 13, a personal First Aid Kit is composed out of
the learned long-term beneficial survival strategies aimed
to prevent relapse.
Control condition: waiting list
Patients assigned to the waiting list condition, wait during
the group training of 13 weeks, after which they start with
their training.
Outcome measurements
(Cost-)effectiveness is measured with three self-report
questionnaires, which are sent to patients' home to be
completed before randomization, at the end of the train-
ing or waiting list period, after 3 and 12 months after the
training (see Figure 1).
1) Short Form Health Survey (SF-36) [23]
The SF-36 measures functional health and well-being
during the past four weeks with the following eight
multi-item scales: Physical functioning, Role function-
ing physical, Bodily pain, General health, Vitality,
Social functioning, Role functioning emotional and
Mental health. The scores of the SF-36 can also be
summarized in the Mental and the Physical summary
scores [24]. Furthermore, a utility score can be derived
from 11 items of the SF-36. These 11 items define six
dimensions of health, the SF-6D; Physical function-
ing, Role limitations (Role functioning physical in
combination with Role functioning emotional), Bod-
ily pain, Social functioning, Vitality and Mental
health. The outcome of the SF-6D can be converted
into Quality Adjusted Life Years (QALYs), the pre-
ferred outcome in health economics, using formerly
called 'valuations studies' [25].
2) Symptom Checklist Revised (SCL-90-R) [26]
The SCL-90-R measures a broad range of symptoms
and their intensity during the past week with the fol-
lowing eight multi-item scales: Phobic anxiety, Anxi-
ety, Depression, Somatization, Obsessive-compulsive,
Interpersonal sensitivity, Hostility and Sleep difficul-
ties. The scores of the SCL-90-R can be summarized in
the Global severity index, reflecting the overall psy-
chological distress.
3) Trimbos/iMTA Questionnaire for Costs associated with
Psychiatric Illness (TiC-P) [27]
The TiC-P measures direct medical costs due to health-
care utilization during the past four weeks, excluding
the group training itself. The costs of the training itself
are calculated using the records of the institution. The
TiC-P also registers the indirect non-medical costs due
to productivity loss during the past two weeks. This
second part of the questionnaire about indirect costs is
based on the short form of the Health and Labour
Questionnaire (HLQ).BMC Public Health 2009, 9:251 http://www.biomedcentral.com/1471-2458/9/251
Page 7 of 9
(page number not for citation purposes)
Outcome measurements: clinical evaluation
The aim of the clinical evaluation is to investigate the
effectiveness of the group training by comparing the
improvement of quality of life gained in the training
group to the one in the waiting list group. Primary out-
come measure is the Mental and Physical summary score
of the SF-36. Secondary outcomes are the eight individual
scales of the SF-36 and the scales of the SCL-90-R.
Outcome measurements: economic evaluation
The aim of the economic evaluation is to investigate cost-
effectiveness of the group training in terms of cost per
Quality Adjusted Life Years (QALYs). QALYs are estimated
by converting SF-6D into utilities by means of the prefer-
ence-based UK tariff [25]. Indirect costs for employed
patients are measured with the TiC-P by the reported
duration of sick leave and the production loss without
sick leave. The indirect costs of production loss due to sick
leave are computed by multiplying the number of sick
leave's day with the average net income per worker related
to age and gender. By a long-term sick leave, the friction-
cost method is applied to assess the productivity loss,
using a friction period of 5 months.
Sample size calculation
To determine the required sample size for measuring dif-
ferences in quality of life between the two conditions
(group training and waiting list), the sample size is calcu-
lated by power analysis. The effect size of cognitive behav-
ioral therapy for quality of life is not well known, because
in other effect studies the outcome is usually measured in
terms of physical symptoms. Therefore, we have to use
effect size of cognitive behavioral therapy for physical
symptoms as an available estimator for the (shortage of)
quality of life. The effect size of cognitive behavioral ther-
apy for physical symptoms ranges from .00 to .95 [8], sug-
gesting a medium effect for cognitive behavioral therapy
for physical symptoms. Assuming this effect also applies
for quality of life, the magnitude of the effect size follow-
ing Cohen's (1988) [28] is 0.50. With a power of .80 and
an alpha of .05 (two-tailed), a sample size of 100 patients
(50 in each condition) is required.
Statistical analyses
The comparability of the patients' baseline-variables
between the two conditions (group training and waiting
list) is analyzed with the two-tailed t-tests for independent
samples for the continuous variables, with the two-tailed
Mann-Whitney U-tests for the ordinal variables and with
the chi-square tests for the categorical variables. If the
patients in the two conditions are not comparable on one
or more baseline-variables, those variables will be utilized
as covariables in the subsequent analyses.
Statistical analyses: clinical evaluation
The clinical evaluation is conducted according to the
intention-to-treat principle. The effectiveness of the group
training for primary and secondary outcome measures is
analyzed with mixed modeling (i.c. random regression
modeling). Baseline measurements, corresponding to the
subsequent outcome measurements, are entered as covari-
ables. This method of mixed modeling for repeated meas-
urements enables the use of flexible error covariance
structures. In addition, the predictive performance of
baseline-variables, especially personality variables, on
effectiveness can be estimated.
Statistical analyses: economic evaluation
The economic evaluation is conducted from a societal per-
spective, the preferred perspective in health economic
evaluations [29]. This means that all costs are included:
the direct medical costs, the indirect medical costs and the
indirect costs associated with productivity loss of patients.
Adopting a societal perspective also means that all rele-
vant effects and all costs beyond the time frame of the trial
should be measured. In this case, the differences between
group training and waiting list can only be measured
empirically till 13 weeks, but relevant effects and costs
might occur beyond that artificial time horizon. For this
reason, we will estimate effects and costs till 2 years, using
a Markov model [30]. By making the Markov model prob-
abilistic, we will be able to implement multiple sensitivity
tests simultaneously and test for specific model assump-
tions. A critical assumption will be the extrapolation of
the effect beyond 13 weeks. This assumption will be
explored by calculating the minimal duration that the
group training should be effective, in order to achieve a
satisfactory level of cost-effectiveness.
Ethical considerations
The Medical Ethical Committee of Erasmus Medical
Center, Rotterdam, The Netherlands, has approved this
study, registered under MEC-2004-191.
Discussion
The primary aim of our study is to investigate (cost-)effec-
tiveness of an easily accessible protocollized group train-
ing for patients with UPS in primary care in the daily
practice of our mental healthcare institution, Riagg Rijn-
mond, The Netherlands.
Investigating the (cost-)effectiveness of our training in the
daily practice of a mental healthcare institution has its
benefits and its limitations. The huge advantage of inves-
tigating the (cost-)effectiveness in the daily practice is that
if (cost-)effectiveness is shown, the group training can be
started without the delay of practical implementation
issues. The limitations for this study are less possibilities
for exclusion of patients and for the control condition.BMC Public Health 2009, 9:251 http://www.biomedcentral.com/1471-2458/9/251
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Consequently, the (cost-)effectiveness is explored in a het-
erogeneous group of patients. Measuring heterogeneity of
our study population with the SCID-I/P and VKP but not
excluding co-morbidity and drawing attention to the
group training by announcements to both physicians and
patients acumilate this heterogeneity. Patients being
referred on their own initiative are probably more moti-
vated than patients being referred on their physician's ini-
tiative. On the one hand, this enhances the probability of
a representative study population, whose heterogeneity
will be equally divided between the two conditions by
randomization. Furthermore, this heterogeneous study
population is real practice, making the study results real-
istic estimates of that practice. On the other hand, the
group training might be effective by only treating the co-
morbidity, like anxiety. Analyzing the predictability of
this co-morbidity and other baseline variables on (cost-
)effectiveness can solve this limitation.
Because the daily practice only allows a waiting list for a
short period, the follow-up measurements do not have a
control condition. Repeated measurements in the same
patients and using a probabilistic model can solve this
problem partly.
If we show that our group training is feasible in daily prac-
tice and (cost-)effective, more patients with UPS could be
served, their quality of life could be improved while costs
might be decreased.
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